Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07075380

National Survey on Physical and Sports Activity of Adults With Epilepsy

Epilepsy affects nearly 600,000 people in France and causes neurological seizures that can lead to lasting impairments and stigma. Physical activity provides many benefits, including improved quality of life, social participation, and reduced stress and seizure frequency. Despite these benefits, people with epilepsy tend to be less active than the general population due to barriers such as fear of seizures during exercise, fatigue, and negative beliefs about the disease. Psychological factors and stigma influence physical activity engagement and affect how the disease is integrated into personal identity, impacting quality of life and treatment adherence. Studying the role of anxiety, stigma, and illness identity, as well as their interaction with physical activity identity, is essential to better understand and promote physical activity among people with epilepsy.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Institut La Teppe

Tain-l'Hermitage, 26600, France

Location status: Recruiting

Location contact

Nicolas Mezouar, Dr

CONTACT

[email protected]

+33475075959

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals self-reporting as over 18 years old
  • Individuals self-reporting having epilepsy

Exclusion criteria

  • not having completed secondary questionnaire at 6 months from inclusion

Treatment and study plan

Online Questionnaire

Behavioral

Online questionnaire assessing physical activity level, completed twice at a 6-month interval.

Primary outcomes

  1. maintained physical activity

    Time frame: Day 0 and Month 6

    Physical activity level will be measured using an adapted version of the Modifiable Activity Questionnaire (MAQ) at inclusion and 6 months later as a criterion for behavior maintenance. MAQ ranges starts from 0 with no maximum limit. A higher value means a higher physical activity level.

Study contacts

Contact information is provided by the study sponsor or research team.

Amelie Yavchitz, Dr

CONTACT

[email protected]

+33148036454

Sponsors and collaborators

Lead sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Network

Registry information

Acronym: ENAPSE

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Jul 20, 2025
Registry last updated
Dec 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.